Halliday C, Hoile R, Sorrell T, James G, Yadav S,
Shaw P, Bleakley M, Bradstock K, Chen S (2006)
Role of prospective screening of blood for invasive
aspergillosis by polymerase chain reaction in febrile
neutropenic recipients of haematopoietic stem cell
transplants and patients with acute leukaemia. Br J
Haematol 132:478–486
Hizel K, Kokturk N, Kalkanci A, Ozturk C, Kustimur S,
Tufan M (2004) Polymerase chain reaction in the
diagnosis of invasive aspergillosis. Mycoses
47:338–342
Kousha M, Tadi R, Soubani AO (2011) Pulmonary asper-
gillosis: a clinical review. Eur Respir Rev 20:156–174
Leeflang MM, Debets-Ossenkopp Y, Visser CE, Scholten
RJ, Hooft L, Bijlmer HA, Reitsma JB, Bossuyt PM,
Vandenbroucke-Grauls CM (2008) Galactomannan
detection for invasive aspergillosis in immunocom-
promized patients. Cochrane Database Syst Rev 4:
CD007394. doi:10.1002/14651858.CD007394
Maertens J, Theunissen K, Verhoef G, Verschakelen J,
Lagrou K, Verbeken E, Wilmer A, Verhaegen J,
Boogaerts M, Van Eldere J (2005) Galactomannan
and computed tomography-based preemptive antifun-
gal therapy in neutropenic patients at high risk for
invasive fungal infection: a prospective feasibility
study. Clin Infect Dis 41:1242–1250
Maertens J, Theunissen K, Lodewyck T, Lagrou K, Van
Eldere J (2007) Advances in the serological diagnosis
of invasive Aspergillus infections in patients with
haematological disorders. Mycoses Suppl 1:2–17
Marks DI, Pagliuca A, Kibbler CC, Glasmacher A,
Heussel CP, Kantecki M, Miller PJS, Ribaud P,
Schlamm HT, Solano C, Cook G, IMPROVIT Study
Group (2011) Voriconazole versus itraconazole for
antifungal prophylaxis following allogeneic
haematopoietic stem-cell transplantation. Br J
Haematol 155:318–327
Marr KA, Laverdiere M, Gugel A, Leisenring W (2005)
Antifungal therapy decreases sensitivity of the Asper-
gillus galactomannan enzyme immunoassay. Clin
Infect Dis 40:1762–1769
Maturu VN, Agarwal R (2015) Acute invasive pulmonary
aspergillosis complicating allergic bronchopulmonary
aspergillosis: case report and systematic review.
Mycopathologia 180:209–215
Okuturlar Y, Ozkalemkas F, Ener B, Serin SO, Kazak E,
Ozcelik T, Ozkocaman V, Ozkan HA, Akalin H,
Gunaldi M, Ali R (2015) Serum galactomannan levels
in the diagnosis of invasive aspergillosis. Korean J
Intern Med 30:899–905
Pfeiffer CD, Fine JP, Safdar N (2006) Diagnosis of inva-
sive aspergillosis using a galactomannan assay: a
meta-analysis. Clin Infect Dis 42:1417–1427
Santos T, Aguiar B, Santos L, Romaozinho C, Tome R,
Macario F, Alves R, Campos M, Mota A (2015) Inva-
sive fungal infections after kidney transplantation: a
single-center experience. Transplant Proc 47:971–975
Singh N, Obman A, Husain S, Aspinall S, Mietzner S,
Stout JE (2004) Reactivity of platelia Aspergillus
galactomannan antigen with piperacillin-tazobactam:
clinical implications based on achievable
concentrations in serum. Antimicrob Agents
Chemother 48:1989–1992
S€onmez A, Eksi F, Pehlivan M, Haydaroglu Sahin H
(2015) Investigating the presence of fungal agents in
febrile neutropenic patients using different
microbiological, serological, and molecular methods.
Bosn J Basic Med Sci 15:40–47
Wheat LJ, Walsh TJ (2008) Diagnosis of invasive asper-
gillosis by galactomannan antigenemia detection
using an enzyme immunoassay. Eur J Clin Microbiol
Infect Dis 27:245–251
Yeo SF, Wong B (2002) Current status of nonculture
methods for diagnosis of invasive fungal infections.
Clin Microbiol Rev 15:465–468Diagnosis of Invasive Pulmonary Aspergillosis 33